ProteomeTech (303360) Stock Overview

ProteomeTech Inc. designs, develops, and sells diagnostic kits in South Korea. The company offers PROTIA Allergy-Q, an assay kit for quantitative determination of specific IgE antibodies against individual allergens in human serum using immunoblotting technique; ImmuneCheck IgG, a whole blood test kit for total IgG concentration measurement; and TriCheck-C, an in vitro diagnostic kit for the qualitative test of human chorionic gonadotropin in human urine samples for the pregnancy diagnosis. It also provides protia food iga, a chronic food intolerance test to identify the foods that do not fit, and stay healthy; anitia canine ige, a serum to identify the cause of the allergy; anicheck bovine igg, a colostrum for feeding calves. In addition, the company provides genedania, a kit for the detection of nucleic acid from SARS-CoV-2.Further, it offers 2-D electrophoresis, mass spectrometry, post translational, and protein services. ProteomeTech Inc. was founded in 2000 and is based in Seoul, South Korea.